{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:25:01Z","timestamp":1773408301877,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s10067-005-1166-x","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T09:19:29Z","timestamp":1127294369000},"page":"246-250","source":"Crossref","is-referenced-by-count":24,"title":["IgG and IgM isotypes of anti-cardiolipin and anti-\u03b2 2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events"],"prefix":"10.1007","volume":"25","author":[{"given":"Henning","family":"Locht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Wiik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"4","key":"1166_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"1166_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1568-9972(01)00005-2","volume":"1","author":"G Ruiz-Irastorza","year":"2002","unstructured":"Ruiz-Irastorza G, Khamashta MA, Hughes GRV (2002) Hughes syndrome crosses boundaries. Autoimmun Rev 1:43\u201348","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1166_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","volume":"68","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J et al (1989) The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68(6):366\u2013374","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1166_CR4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346(10):752\u2013763","journal-title":"N Engl J Med"},{"issue":"8","key":"1166_CR5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/01.STR.30.8.1561","volume":"30","author":"S Tuhrim","year":"1999","unstructured":"Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME et al (1999) Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 30(8):1561\u20131565","journal-title":"Stroke"},{"issue":"6","key":"1166_CR6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.STR.31.6.1289","volume":"31","author":"E Ahmed","year":"2000","unstructured":"Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31(6): 1289\u20131293","journal-title":"Stroke"},{"issue":"9","key":"1166_CR7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.29.9.1759","volume":"29","author":"V Toschi","year":"1998","unstructured":"Toschi V, Motta A, Castelli C, Paracchini ML, Zerbi D, Gibelli A (1998) High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29(9):1759\u20131764","journal-title":"Stroke"},{"issue":"12","key":"1166_CR8","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/01.STR.31.12.3067","volume":"31","author":"CD Bushnell","year":"2000","unstructured":"Bushnell CD, Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31(12):3067\u20133078","journal-title":"Stroke"},{"issue":"4","key":"1166_CR9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","volume":"94","author":"EN Harris","year":"1990","unstructured":"Harris EN (1990) Special report. The second international anti-cardiolipin standardization workshop\/the kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 94(4):476\u201384","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"1166_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1191\/096120301701549651","volume":"10","author":"A Voss","year":"2001","unstructured":"Voss A, Jacobsen S, Heegaard NH (2001) Association of beta 2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 10(8):533\u2013538","journal-title":"Lupus"},{"issue":"7","key":"1166_CR11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/clinchem\/42.7.1116","volume":"42","author":"EN Erickson","year":"1996","unstructured":"Erickson EN Jr, Najmey SS, Keil LB, El Kadi HS, DeBari VA (1996) Reference calibrators for IgG antibodies to beta 2-glycoprotein I: preparation, properties and availability to investigators. Clin Chem 42(7): 1116\u20131117","journal-title":"Clin Chem"},{"issue":"7","key":"1166_CR12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphosphol-ipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309\u20131311","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1166_CR13","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/01.STR.29.11.2245","volume":"29","author":"P Verro","year":"1998","unstructured":"Verro P, Levine SR, Tietjen GE (1998) Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29(11):2245\u20132253","journal-title":"Stroke"},{"issue":"289","key":"1166_CR14","first-page":"397","volume":"79","author":"KK Chakravarty","year":"1991","unstructured":"Chakravarty KK, Byron MA, Webley M, Durkin CJ, Hillawi AH, Bodley R et al (1991) Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus. Q J Med 79(289):397\u2013405","journal-title":"Q J Med"},{"issue":"12","key":"1166_CR15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","volume":"117","author":"KS Ginsburg","year":"1992","unstructured":"Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH et al (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117(12):997\u20131002","journal-title":"Ann Intern Med"},{"issue":"3","key":"1166_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1468-1331.1998.530287.x","volume":"5","author":"M Szczepanski","year":"1998","unstructured":"Szczepanski M, Cieslak E, Gardas A, Bauer A, Majkowski J (1998) Prevalence of high IgM anticardiolipins in patients with ischemic stroke. Eur J Neurol 5(3):287\u2013290","journal-title":"Eur J Neurol"},{"issue":"5","key":"1166_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002281-200109000-00006","volume":"13","author":"PL Meroni","year":"2001","unstructured":"Meroni PL, Riboldi P (2001) Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 13(5):377\u2013382","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"1166_CR18","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V84.9.2854.2854","volume":"84","author":"RA Roubey","year":"1994","unstructured":"Roubey RA (1994) Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other \u201cantiphospholipid\u201d autoantibodies. Blood 84(9):2854\u20132867","journal-title":"Blood"},{"issue":"3","key":"1166_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/jaut.1994.1024","volume":"7","author":"J Vazquez-Mellado","year":"1994","unstructured":"Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D (1994) Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 7(3):335\u2013348","journal-title":"J Autoimmun"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-1166-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-1166-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T19:25:41Z","timestamp":1586460341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-1166-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-1166-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}